in millions of euros, unless otherwise stated, | |||
for the year ended December 31 | 2024 | 2023 | |
Revenues | Note 5/6 | ||
Cost of revenues | Note 5 | ( | ( |
Gross profit | Note 5 | ||
Sales costs | Note 9 | ( | ( |
General and administrative costs | Note 10 | ( | ( |
Total operating expenses | Note 5 | ( | ( |
Other gains and (losses) | Note 11 | ( | ( |
Operating profit | Note 5 | ||
Financing income | |||
Financing costs | ( | ( | |
Other finance income and (costs) | ( | ||
Total financing results | Note 14 | ( | ( |
Share of profit of equity-accounted associates, net of tax | Note 20 | ||
Profit before tax | |||
Income tax expense | Note 15 | ( | ( |
Profit for the year | |||
Attributable to: | |||
– Owners of the company | |||
– Non-controlling interests | Note 16 | ||
Profit for the year | |||
Earnings per share (EPS) (€) | |||
Basic EPS | Note 7 | ||
Diluted EPS | Note 7 |
in millions of euros, | |||
for the year ended December 31 | 2024 | 2023 | |
Comprehensive income | |||
Profit for the year | |||
Other comprehensive income | |||
Items that are or may be reclassified subsequently to the consolidated statement ofprofitorloss: | |||
Exchange differences on translation of foreign operations | ( | ||
Exchange differences on translation of equity-accounted | |||
associates | Note 20 | ( | |
Recycling of foreign exchange differences on loss of control | Note 8 | ( | |
Gains/(losses) on hedges of net investments in foreign operations | ( | ||
Gains/(losses) on cash flow hedges | ( | ( | |
Net change in fair value of cash flow hedges reclassified to the consolidated statementofprofit or loss | Note 14 | ||
Items that will not be reclassified to the consolidated | |||
statement of profit or loss: | |||
Remeasurement gains/(losses) on defined benefit plans | Note 30 | ( | ( |
Other comprehensive income/(loss) for the year, before tax | ( | ||
Income tax on items that are or may be reclassified | |||
subsequently to the consolidated statement ofprofit or loss | |||
Income tax on items that will not be reclassified to the consolidated statement of profit orloss | |||
Income tax on other comprehensive income | Note 22 | ||
Other comprehensive income/(loss) for the year | ( | ||
Total comprehensive income for the year | |||
Attributable to: | |||
– Owners of the company | |||
– Non-controlling interests | |||
Total comprehensive income for the year |
in millions of euros, for the year ended December 31 | 2024 | 2023 | |
Cash flows from operating activities | |||
Profit for the year | |||
Adjustments for: | |||
Income tax expense | Note 15 | ||
Share of profit of equity-accounted associates, net of tax | Note 20 | ( | ( |
Financing results | Note 14 | ||
Amortization, impairment, and depreciation | Note 13 | ||
Book (profit)/loss on disposal of operations and non-current | |||
assets | ( | ( | |
Fair value changes of contingent considerations | Note 11 | ||
Additions to and releases from provisions | Note 31 | ||
Appropriation of provisions | Note 31 | ( | ( |
Changes in employee benefit provisions | ( | ( | |
Share-based payments | Note 12 | ||
Other adjustments | |||
Adjustments excluding autonomous movements in working capital | |||
Inventories | ( | ||
Contract assets | Note 24 | ( | |
Trade and other receivables | ( | ||
Deferred income | Note 24 | ||
Other contract liabilities | Note 24 | ( | |
Trade and other payables | |||
Autonomous movements in working capital | |||
Total adjustments | |||
Net cash flows from operations | |||
Interest paid (including the interest portion of lease payments) | ( | ( | |
Interest received | |||
Paid income tax | Note 22 | ( | ( |
Net cash from operating activities |
in millions of euros, for the year ended December 31 | 2024 | 2023 | |
Cash flows from investing activities | |||
Capital expenditure | Note 17/18 | ( | ( |
Proceeds from disposal of other intangible assets and property, plant, and equipment | |||
Acquisition spending, net of cash acquired | Note 8 | ( | ( |
Receipts from divestments, net of cash disposed | Note 8 | ||
Dividends received | |||
Cash used for settlement of net investment hedges | ( | ||
Net cash used in investing activities | ( | ( | |
Cash flows from financing activities | |||
Repayment of loans | ( | ( | |
Proceeds from new loans | |||
Repayment of principal portion of lease liabilities | Note 19 | ( | ( |
Collateral received/(paid) | ( | ||
Repurchased shares | Note 32 | ( | ( |
Dividends paid | ( | ( | |
Net cash used in financing activities | ( | ( | |
Net cash flows before effect of exchange differences | ( | ( | |
Exchange differences on cash and cash equivalents and bank | |||
overdrafts | ( | ||
Net change in cash and cash equivalents and bank overdrafts | ( | ( | |
Cash and cash equivalents less bank overdrafts at January 1 | |||
Cash and cash equivalents less bank overdrafts at December 31 | Note 26 | ||
Add: Bank overdrafts at December 31 | Note 26 | ||
Cash and cash equivalents in the consolidated statement of financial position at December 31 | Note 26 |
in millions of euros, at December 31 | 2024 | 2023 | |
Non-current assets | |||
Goodwill | Note 17 | ||
Intangible assets other than goodwill | Note 17 | ||
Property, plant, and equipment | Note 18 | ||
Right-of-use assets | Note 19 | ||
Investments in equity-accounted associates | Note 20 | ||
Financial assets | Note 21 | ||
Non-current contract assets | Note 24 | ||
Non-current other receivables | Note 25 | ||
Deferred tax assets | Note 22 | ||
Total non-current assets | |||
Current assets | |||
Inventories | Note 23 | ||
Contract assets | Note 24 | ||
Trade receivables | Note 24 | ||
Other receivables | Note 25 | ||
Current income tax assets | Note 22 | ||
Cash and cash equivalents | Note 26 | ||
Total current assets | |||
Total assets |
in millions of euros, at December 31 | 2024 | 2023 | |
Equity | |||
Issued share capital | Note 32 | ||
Share premium reserve | |||
Legal reserves | |||
Treasury shares | ( | ( | |
Retained earnings | |||
Equity attributable to the owners of the company | Note 46 | ||
Non-controlling interests | Note 16 | ||
Total equity | |||
Non-current liabilities | |||
Bonds | |||
Private placements | |||
Lease liabilities | |||
Other long-term debt | |||
Total long-term debt | Note 28 | ||
Deferred tax liabilities | Note 22 | ||
Employee benefits | Note 30 | ||
Provisions | Note 31 | ||
Non-current deferred income | Note 24 | ||
Total non-current liabilities | |||
Current liabilities | |||
Deferred income | Note 24 | ||
Other contract liabilities | Note 24 | ||
Trade and other payables | Note 27 | ||
Current income tax liabilities | Note 22 | ||
Short-term provisions | Note 31 | ||
Borrowings and bank overdrafts | Note 28 | ||
Short-term bonds | Note 28 | ||
Short-term lease liabilities | Note 28 | ||
Total current liabilities | |||
Total liabilities | |||
Total equity and liabilities |
Non- | ||||||||||
Legal reserve | Hedge | Translation | Treasury | Retained | Shareholders’ | controlling | ||||
participations | reserve | reserve | shares | earnings | equity | interests | Total equity | |||
Balance at January 1, 2023 | ( | ( | ||||||||
Profit for the year | ||||||||||
Other comprehensive income/(loss) for the year | ( | ( | ( | ( | ( | |||||
Total comprehensive income/(loss) for theyear | ( | ( | ||||||||
Transactions with owners of the company, recognized directly | ||||||||||
in equity: | ||||||||||
Share-based payments | ||||||||||
Cancelation of shares | ( | ( | ||||||||
Release LTIP shares | ( | |||||||||
Final cash dividend 2022 | ( | ( | ( | |||||||
Interim cash dividend 2023 | ( | ( | ( | |||||||
Repurchased shares | ( | ( | ( | |||||||
Other movements | ( | |||||||||
Balance at December 31, 2023 | ( | ( | ||||||||
Balance at January 1, 2024 | ( | ( | ||||||||
Profit for the year | ||||||||||
Other comprehensive income/(loss) for the year | ( | ( | ||||||||
Total comprehensive income for theyear | ( | |||||||||
Transactions with owners of the company, recognized directly | ||||||||||
in equity: | ||||||||||
Share-based payments | ||||||||||
Cancelation of shares | ( | ( | ||||||||
Release LTIP shares | ( | |||||||||
Final cash dividend 2023 | ( | ( | ( | ( | ||||||
Interim cash dividend 2024 | ( | ( | ( | |||||||
Repurchased shares | ( | ( | ( | |||||||
Other movements | ( | |||||||||
Balance at December 31, 2024 | ( | ( |
The group maintains operations across the |
Main currency exchange rates | ||
rates to the euro | 2024 | 2023 |
U.S. dollar (average) | 1.08 | 1.08 |
U.S. dollar (at December 31) | 1.04 | 1.11 |
Note 5 – Segment reporting | ||||||||||||||
Financial & | ||||||||||||||
Tax & | Corporate | Legal & | Corporate | |||||||||||
in millions of euros, unless otherwise stated | Health | Accounting | Compliance | Regulatory | Performance & ESG | Corporate * | Total | |||||||
reporting by segment | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 |
Revenues from contracts with third parties | 1,584 | 1,508 | 1,561 | 1,466 | 1,105 | 1,052 | 946 | 875 | 720 | 683 | – | – | 5,916 | 5,584 |
Cost of revenues | (479) | (460) | (421) | (399) | (255) | (247) | (257) | (257) | (214) | (213) | – | – | (1,626) | (1,576) |
Gross profit | 1,105 | 1,048 | 1,140 | 1,067 | 850 | 805 | 689 | 618 | 506 | 470 | 0 | 0 | 4,290 | 4,008 |
Sales costs | (237) | (237) | (227) | (217) | (138) | (134) | (162) | (148) | (205) | (193) | – | – | (969) | (929) |
General and administrative costs | (424) | (401) | (413) | (388) | (297) | (286) | (378) | (358) | (289) | (250) | (69) | (66) | (1,870) | (1,749) |
Total operating expenses | (661) | (638) | (640) | (605) | (435) | (420) | (540) | (506) | (494) | (443) | (69) | (66) | (2,839) | (2,678) |
Other gains and (losses) | (4) | (4) | (3) | (2) | 0 | (2) | (4) | 2 | 1 | (1) | – | – | (10) | (7) |
Operating profit | 440 | 406 | 497 | 460 | 415 | 383 | 145 | 114 | 13 | 26 | (69) | (66) | 1,441 | 1,323 |
Amortization of acquired identifiable intangible assets | 34 | 44 | 19 | 17 | 18 | 18 | 27 | 26 | 49 | 41 | – | – | 147 | 146 |
Impairment of goodwill | 2 | – | – | – | – | – | – | – | – | – | – | – | 2 | 0 |
Non-benchmark items in operating profit | 4 | 4 | 3 | 2 | 0 | 2 | 4 | (2) | (1) | 1 | – | – | 10 | 7 |
Adjusted operating profit | 480 | 454 | 519 | 479 | 433 | 403 | 176 | 138 | 61 | 68 | (69) | (66) | 1,600 | 1,476 |
Amortization of other intangible assets and depreciation of PPE and right-of-use assets | (47) | (47) | (80) | (77) | (43) | (46) | (64) | (62) | (73) | (62) | 0 | 0 | (307) | (294) |
Impairment of other intangible assets, PPE, and right-of-use assets | (13) | 0 | (4) | (2) | (4) | 0 | (2) | (1) | 0 | (2) | – | – | (23) | (5) |
Goodwill and acquired identifiable intangible assets at December 31 | 1,300 | 1,260 | 1,656 | 1,284 | 1,210 | 1,159 | 755 | 725 | 727 | 766 | – | – | 5,648 | 5,194 |
Net capital expenditure | 43 | 49 | 68 | 74 | 54 | 58 | 53 | 58 | 95 | 84 | 0 | 0 | 313 | 323 |
Number of FTEs at December 31 | 3,401 | 3,333 | 7,159 | 7,276 | 3,030 | 3,056 | 4,147 | 4,033 | 3,315 | 3,215 | 148 | 143 | 21,200 | 21,056 |
Total non-current assets per geographic region | ||||
2024 | 2023 | |||
in millions of euros, unless otherwise stated | % | % | ||
703 | 11 | 715 | 11 | |
Europe (excluding the Netherlands) | 1,642 | 24 | 1,302 | 21 |
U.S. and Canada | 4,352 | 64 | 4,176 | 67 |
Asia Pacific | 71 | 1 | 76 | 1 |
Rest of World | 17 | 0 | 20 | 0 |
Total | 6,785 | 100 | 6,289 | 100 |
Note 6 – Revenues | ||
2024 | 2023 | |
Revenues from contracts with third parties | 5,916 | 5,584 |
Revenues by recognition pattern and contract length | Tax & | Financial & Corporate | Legal & | Corporate | ||||||||
Health | Accounting | Compliance | Regulatory | Performance & ESG | Total | |||||||
reporting per segment | 2024 | 2023 * | 2024 | 2023 * | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 * |
Revenue by recognition pattern | ||||||||||||
At a point in time recognition | 259 | 253 | 197 | 193 | 379 | 366 | 252 | 246 | 70 | 103 | 1,157 | 1,161 |
Over time recognition | 1,325 | 1,255 | 1,364 | 1,273 | 726 | 686 | 694 | 629 | 650 | 580 | 4,759 | 4,423 |
Revenues from contracts with third parties | 1,584 | 1,508 | 1,561 | 1,466 | 1,105 | 1,052 | 946 | 875 | 720 | 683 | 5,916 | 5,584 |
Revenue by contract length | ||||||||||||
Contracts one year or less | 1,010 | 936 | 1,404 | 1,304 | 887 | 844 | 685 | 644 | 339 | 354 | 4,325 | 4,082 |
Multi-year contracts | 574 | 572 | 157 | 162 | 218 | 208 | 261 | 231 | 381 | 329 | 1,591 | 1,502 |
Revenues from contracts with third parties | 1,584 | 1,508 | 1,561 | 1,466 | 1,105 | 1,052 | 946 | 875 | 720 | 683 | 5,916 | 5,584 |
Restated for certain reclassifications. See Note 1 – General and basis of preparation. | ||||||||||||
Revenues by media format | Tax & | Financial & Corporate | Legal & | Corporate | ||||||||
Health | Accounting | Compliance | Regulatory | Performance & ESG | Total | |||||||
reporting per segment | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 |
Digital | 1,427 | 1,348 | 1,495 | 1,398 | 578 | 558 | 815 | 736 | 720 | 683 | 5,035 | 4,723 |
Services | 4 | 4 | 34 | 33 | 522 | 488 | 9 | 9 | 0 | 0 | 569 | 534 |
Print | 153 | 156 | 32 | 35 | 5 | 6 | 122 | 130 | – | – | 312 | 327 |
Revenues from contracts with third parties | 1,584 | 1,508 | 1,561 | 1,466 | 1,105 | 1,052 | 946 | 875 | 720 | 683 | 5,916 | 5,584 |
Recurring/non-recurring revenues | ||||||||||||
Tax & | Financial & Corporate | Legal & | Corporate | |||||||||
Health | Accounting | Compliance | Regulatory | Performance & ESG | Total | |||||||
reporting per segment | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 |
Recurring revenues | 1,449 | 1,374 | 1,431 | 1,339 | 744 | 704 | 746 | 683 | 498 | 443 | 4,868 | 4,543 |
Non-recurring revenues | 135 | 134 | 130 | 127 | 361 | 348 | 200 | 192 | 222 | 240 | 1,048 | 1,041 |
Revenues from contracts with third parties | 1,584 | 1,508 | 1,561 | 1,466 | 1,105 | 1,052 | 946 | 875 | 720 | 683 | 5,916 | 5,584 |
Revenues by type | ||||
Digital and service subscription | 4,458 | 2024 | 4,134 | 2023 |
Print subscription | 125 | 136 | ||
Other recurring | 285 | 273 | ||
Total recurring revenues | 4,868 | 4,543 | ||
Print books | 120 | 120 | ||
Legal Services transactional | 306 | 283 | ||
Financial Services transactional | 130 | 128 | ||
Other non-recurring * | 492 | 510 | ||
Total non-recurring revenues | 1,048 | 1,041 | ||
Revenues from contracts with third parties | 5,916 | 5,584 |
Revenues per geographic region | ||||
2024 | 2023 | |||
in millions of euros, unless otherwise stated | % | % | ||
The Netherlands | 248 | 4 | 227 | 4 |
Europe (excluding the Netherlands) | 1,415 | 24 | 1,342 | 24 |
U.S. and Canada | 3,791 | 64 | 3,577 | 64 |
Asia Pacific | 351 | 6 | 345 | 6 |
Rest of World | 111 | 2 | 93 | 2 |
Revenues from contracts with third parties | 5,916 | 100 | 5,584 | 100 |
Profit for the year | ||
2024 | 2023 | |
Profit for the year attributable to the owners of the company (A) | 1,079 | 1,007 |
Weighted-average number of ordinary shares for the year | |||
in millions of shares, unless otherwise stated | 2024 | 2023 | |
Outstanding ordinary shares at January 1 | Note 32 | 248.5 | 257.5 |
Effect of cancelation of shares | (2.9) | (3.4) | |
Effect of repurchased shares | (8.1) | (9.2) | |
Weighted-average number of ordinary shares (B) | 237.5 | 244.9 | |
Basic EPS (A/B) (€) | 4.54 | 4.11 |
Diluted weighted-average number of ordinary shares for the year | ||
in millions of shares, unless otherwise stated | 2024 | 2023 |
Weighted-average number of ordinary shares (B) | 237.5 | 244.9 |
Effect of long-term incentive plan (LTIP) and restricted stock units (RSU) | 0.9 | 1.1 |
Diluted weighted-average number of ordinary shares (C) | 238.4 | 246.0 |
Diluted EPS (A/C) (€) | 4.52 | 4.09 |
Acquisitions | |||||
2024 | 2023 | ||||
Carrying | Fair value | Recognized | Recognized | ||
amounts | adjustments | values | values | ||
Consideration payable in cash | 357 | 60 | |||
Deferred and contingent | |||||
considerations at fair value: | |||||
Non-current | – | 2 | |||
Current | 0 | 2 | |||
Total consideration | 357 | 64 | |||
Intangible assets other than goodwill | Note 17 | 0 | 185 | 185 | 51 |
Other non-current assets | Note 19 | 4 | 4 | 0 | |
Current assets | 33 | 33 | 7 | ||
Current liabilities | (12) | (12) | (9) | ||
Non-current liabilities | Note 28 | (4) | (4) | (1) | |
Employee benefits | (1) | (1) | – | ||
Deferred tax assets/(liabilities) | 0 | (45) | (45) | (10) | |
Fair value of net identifiable assets | 20 | 140 | 160 | 38 | |
Goodwill on acquisitions | Note 17 | 197 | 26 | ||
Cash effect of acquisitions: | |||||
Consideration payable in cash | 357 | 60 | |||
Cash acquired | (25) | (2) | |||
Deferred and contingent | |||||
considerations paid | Note 29 | 3 | 3 | ||
Acquisition spending, net of cash | |||||
acquired | 335 | 61 |
Contribution of 2024 acquisitions | ||||
Adjusted | FTEs at | |||
operating | Profit for | December | ||
in millions of euros, unless otherwise stated | Revenues | profit | the year | 31, 2024 |
Totals excluding the impact of 2024 acquisitions | 5,901 | 1,597 | 1,079 | 21,076 |
Contribution of 2024 acquisitions | 15 | 3 | 0 | 124 |
Totals for the year 2024 | 5,916 | 1,600 | 1,079 | 21,200 |
Pro forma contribution of 2024 acquisitions for the period January 1, 2024, up to acquisition date | ||||
(unaudited) | 28 | 7 | (1) | |
Pro forma totals for the year 2024 | 5,944 | 1,607 | 1,078 | 21,200 |
Divestment-related results on operations and financial assets | |||
2024 | 2023 | ||
Divestment of operations: | |||
Consideration receivable in cash | 1 | 5 | |
Deferred divestment consideration receivable | 0 | – | |
Consideration receivable | 1 | 5 | |
Intangible assets | Note 17 | 3 | – |
Other non-current assets | 0 | – | |
Current assets (including assets held for sale) | 3 | – | |
Current liabilities (including liabilities held for sale) | (6) | – | |
Deferred tax assets/(liabilities) | (1) | 1 | |
Net identifiable assets/(liabilities) | (1) | 1 | |
Reclassification of foreign exchange differences on loss of control to profit or loss, previously recognized in other comprehensive income | 1 | – | |
Book profit/(loss) on divestments of operations | 3 | 4 | |
Divestment-related costs | (5) | 0 | |
Restructuring of stranded costs following divestments | Note 31 | (1) | – |
Divestment-related results included in other gains and (losses) | Note 11 | (3) | 4 |
Divestment of financial assets | |||
Consideration receivable in cash | – | 3 | |
Carrying value of financial assets | – | 0 | |
Divestment-related results included in total financing results | Note 14 | 0 | 3 |
Cash effect of divestments: | |||
Consideration receivable in cash | 1 | 8 | |
Cash included in divested operations | 0 | – | |
Receipts from divestments, net of cash disposed | 1 | 8 |
Note 9 – Sales costs | |||
2024 | 2023 | ||
Marketing and promotion costs | 258 | 253 | |
Sales-related costs – sales commissions directly expensed | 171 | 157 | |
Sales-related costs – amortization of capitalized sales commissions | Note 24 | 29 | 29 |
Other sales-related costs | 407 | 383 | |
Customer support costs | 86 | 84 | |
Additions to and releases from loss allowances on trade receivables | |||
and unbilled revenues | Note 24 | 18 | 23 |
Total | 969 | 929 |
Note 10 – General and administrative costs | |||
2024 | 2023 | ||
Research, development, and editorial costs | 688 | 591 | |
General and administrative operating expenses | 1,033 | 1,012 | |
Amortization and impairment of acquired identifiable | |||
intangible assets and goodwill | Note 13 | 149 | 146 |
Total | 1,870 | 1,749 |
Note 11 – Other gains and (losses) | |||
2024 | 2023 | ||
Acquisition-related costs | Note 8 | (7) | (7) |
Additions to acquisition integration provisions | Note 31 | 0 | (4) |
Fair value changes of contingent considerations | Note 29 | 0 | 0 |
Divestment-related results | Note 8 | (3) | 4 |
Total | (10) | (7) |
Note 12 – Employee benefit expenses | |||
in millions of euros, unless otherwise stated | 2024 | 2023 | |
Salaries and wages and other benefits | 1,963 | 1,848 | |
Social security charges | 167 | 161 | |
Medical cost benefits | 102 | 101 | |
Expenses related to defined contribution plans | 105 | 96 | |
Expenses related to defined benefit plans | Note 30 | (10) | 16 |
Equity-settled share-based payments | Note 33 | 31 | 31 |
Total | 2,358 | 2,253 |
Employees | ||
Headcount at December 31 | 21,635 | 21,438 |
Thereof employed in the Netherlands | 1,180 | 1,176 |
In full-time equivalents at December 31 | 21,200 | 21,056 |
In full-time equivalents average per annum | 21,167 | 20,810 |
Note 13 – Amortization, impairment, and depreciation | |||
2024 | 2023 | ||
Amortization of acquired identifiable intangible assets | Note 17 | 147 | 146 |
Impairment of goodwill | Note 17 | 2 | – |
Amortization of other intangible assets | Note 17 | 223 | 204 |
Impairment of other intangible assets | Note 17 | 22 | 5 |
Depreciation of property, plant, and equipment | Note 18 | 24 | 23 |
Impairment of property, plant, and equipment | Note 18 | 1 | 0 |
Depreciation of right-of-use assets | Note 19 | 60 | 67 |
Total | 479 | 445 |
Note 14 – Financing results | |||
Financing income | 2024 | 2023 | |
Interest income for financial assets measured at amortized cost: | |||
Interest income on short-term bank deposits | 45 | 50 | |
Interest income on bank balances and other Other financing income: | 7 | 5 | |
Derivatives – foreign exchange contracts, not qualifying as hedge | 0 | 0 | |
Total financing income | 52 | 55 | |
Financing costs | |||
Interest expense for financial liabilities measured at amortized cost: | |||
Interest expense on Euro Commercial Paper program and bank | |||
borrowings | (6) | (3) | |
Interest expense on bonds and private placements | (80) | (68) | |
Amortization of fee expense for debt instruments | Note 28 | (3) | (3) |
Interest expense on bank overdrafts and other Other financing expense: | (4) | (3) | |
Unwinding of discount of lease liabilities | Note 28 | (8) | (9) |
Net foreign exchange gains/(losses) | (9) | 7 | |
Items in hedge relationships: | |||
Interest rate swaps | (4) | (3) | |
Foreign exchange gains/(losses) on loans subject to cash flow hedge | 5 | 15 | |
Net change in fair value of cash flow hedges reclassified from other comprehensive income | (5) | (15) | |
Total financing costs | (114) | (82) | |
Net financing results | (62) | (27) | |
Other finance income and (costs) | |||
Divestment-related results on financial assets | Note 8 | – | 3 |
Fair value changes of financial assets | – | 0 | |
Financing component employee benefits | Note 30 | (3) | (3) |
Total other finance income and (costs) | (3) | 0 | |
Total financing results | (65) | (27) |
Note 15 – Income tax expense | |||||
2024 | 2023 | ||||
Current income tax expense | 323 | 300 | |||
Adjustments previous years | (12) | (2) | |||
Deferred tax expense: | |||||
Changes in tax rates | 0 | 0 | |||
Origination and reversal of temporary differences | (12) | (8) | |||
Movements in deferred tax assets and liabilities | Note 22 | (12) | (8) | ||
Total | Note 22 | 299 | 290 |
2024 | 2023 | |||
in millions of euros, unless otherwise stated | % | % | ||
Profit before tax | 1,378 | 1,297 | ||
Income tax expense at the Dutch statutory income | ||||
tax rate | 25.8 | 356 | 25.8 | 335 |
Tax effect of: | ||||
Rate differential | (3.1) | (42) | (2.9) | (38) |
Tax incentives, exempt income, and divestments | (2.0) | (27) | (0.8) | (10) |
Recognized and unrecognized tax losses | 0.5 | 6 | 0.0 | 0 |
Adjustments previous years | (0.8) | (12) | (0.1) | (2) |
Changes in income tax rates | 0.0 | 0 | 0.0 | 0 |
Other taxes | 1.1 | 15 | 0.9 | 11 |
Pillar Two Global Minimum Tax | 0.3 | 5 | – | – |
Non-deductible costs and other items | (0.1) | (2) | (0.5) | (6) |
Total | 21.7 | 299 | 22.4 | 290 |
ownership in % | 2024 | 2023 |
Akadémiai Kiadó Kft. (Budapest, Hungary) | 74 | 74 |
Note 17 – Goodwill and intangible assets other than goodwill | ||||||||||
Acquired | ||||||||||
identifiable | Other | |||||||||
Customer | Technology | intangible | intangible | |||||||
Position at January 1 | Goodwill | relationships | and content | Brand names | Other | assets | assets | 2024 | 2023 | |
Cost value | 4,322 | 1,105 | 690 | 457 | 3 | 2,255 | 2,083 | 8,660 | 8,844 | |
Accumulated amortization and impairment | – | (603) | (377) | (400) | (3) | (1,383) | (1,357) | (2,740) | (2,802) | |
Book value at January 1 | 4,322 | 502 | 313 | 57 | 0 | 872 | 726 | 5,920 | 6,042 | |
Movements | ||||||||||
Investments | – | – | – | – | – | 0 | 293 | 293 | 298 | |
Acquired through business combinations | Note 8 | 197 | 112 | 64 | 9 | – | 185 | 0 | 382 | 77 |
Divestment of operations | Note 8 | 0 | – | – | – | – | 0 | (3) | (3) | – |
Disposal of assets | – | – | – | – | – | 0 | 0 | 0 | 0 | |
Net expenditures | 197 | 112 | 64 | 9 | 0 | 185 | 290 | 672 | 375 | |
Amortization | Note 13 | – | (80) | (58) | (9) | 0 | (147) | (223) | (370) | (350) |
Impairment | Note 13 | (2) | – | – | – | – | 0 | (22) | (24) | (5) |
Reclassifications | (1) | – | – | – | – | 0 | – | (1) | (3) | |
Foreign exchange differences | 194 | 16 | 11 | 1 | 0 | 28 | 26 | 248 | (139) | |
Total movements | 388 | 48 | 17 | 1 | 0 | 66 | 71 | 525 | (122) | |
Position at December 31 | ||||||||||
Cost value | 4,710 | 1,243 | 776 | 487 | 0 | 2,506 | 2,341 | 9,557 | 8,660 | |
Accumulated amortization and impairment | – | (693) | (446) | (429) | 0 | (1,568) | (1,544) | (3,112) | (2,740) | |
Book value at December 31 | 4,710 | 550 | 330 | 58 | 0 | 938 | 797 | 6,445 | 5,920 |
Carrying amounts of goodwill and acquired identifiable intangible assets per operating | ||||
segment | ||||
Acquired | ||||
identifiable | ||||
Goodwill | intangible assets | 2024 | 2023 | |
Health | 1,177 | 123 | 1,300 | 1,260 |
Tax & Accounting | 1,401 | 255 | 1,656 | 1,284 |
Financial & Corporate Compliance | 1,046 | 164 | 1,210 | 1,159 |
Legal & Regulatory | 614 | 141 | 755 | 725 |
Corporate Performance & ESG | 472 | 255 | 727 | 766 |
Total | 4,710 | 938 | 5,648 | 5,194 |
2024 | 2023 | |
Risk-free rate United States (in %) | 4.9 | 4.2 |
Risk-free rate Europe (in %) | 3.0 | 2.8 |
Market risk premium United States (in %) | 5.0 | 5.5 |
Market risk premium Europe (in %) | 5.5 | 6.0 |
Tax rate United States (in %) | 26.0 | 26.0 |
Tax rate Europe (in %) | 25.8 | 25.8 |
Re-levered beta | 0.84 | 0.80 |
Applied | Allowed change (in basis points) | ||||
weighted- | Decrease | Allocated | |||
2024 sensitivity per group of CGUs | average | Decline | Increase | in adjusted | goodwill at |
in millions of euros, unless otherwise | growth | in growth | in discount | operating | December |
stated | rate | rate | rate | profit margin | 31, 2024 |
Health | 2.1% | >300 | >300 | >300 | 1,177 |
Tax & Accounting | 2.1% | >300 | >300 | >300 | 1,401 |
Financial & Corporate Compliance | 2.1% | >300 | >300 | >300 | 1,046 |
Legal & Regulatory | 2.1% | >300 | >300 | >300 | 614 |
Corporate Performance & ESG | 2.1% | >300 | >300 | >300 | 472 |
Total | 2.1% | 4,710 |
Applied | Allowed change (in basis points) | ||||
weighted- | Decrease | Allocated | |||
2023 sensitivity per group of CGUs | average | Decline | Increase | in adjusted | goodwill at |
in millions of euros, unless otherwise | growth | in growth | in discount | operating | December |
stated | rate | rate | rate | profit margin | 31, 2023 |
Health | 2.3% | >300 | >300 | >300 | 1,111 |
Tax & Accounting | 2.2% | >300 | >300 | >300 | 1,188 |
Financial & Corporate Compliance | 2.3% | >300 | >300 | >300 | 987 |
Legal & Regulatory | 2.3% | >300 | >300 | >300 | 573 |
Corporate Performance & ESG | 2.2% | >300 | >300 | >300 | 463 |
Total | 2.3% | 4,322 |
2024 | 2023 | ||
Goodwill | 2 | – | |
Other intangible assets | 22 | 5 | |
Total | Note 13 | 24 | 5 |
Land and | |||||
Position at January 1 | buildings | Other PPE | 2024 | 2023 | |
Cost value | 92 | 176 | 268 | 317 | |
Accumulated depreciation and impairment | (60) | (129) | (189) | (238) | |
Book value at January 1 | 32 | 47 | 79 | 79 | |
Movements | |||||
Investments | 2 | 19 | 21 | 26 | |
Acquired through business | |||||
combinations | 0 | – | 0 | 0 | |
Disposal of assets | 0 | (1) | (1) | (1) | |
Net expenditures | 2 | 18 | 20 | 25 | |
Depreciation | Note 13 | (5) | (19) | (24) | (23) |
Impairment | Note 13 | (1) | 0 | (1) | 0 |
Foreign exchange differences | 2 | 3 | 5 | (2) | |
Total movements | (2) | 2 | 0 | 0 | |
Position at December 31 | |||||
Cost value | 90 | 179 | 269 | 268 | |
Accumulated depreciation and impairment | (60) | (130) | (190) | (189) | |
Book value at December 31 | 30 | 49 | 79 | 79 |
Movement schedule of right-of-use assets | |||||
Other | |||||
Position at January 1 | Real estate | leases | 2024 | 2023 | |
Cost value | 575 | 48 | 623 | 685 | |
Accumulated depreciation and impairment | (353) | (29) | (382) | (402) | |
Book value at January 1 | 222 | 19 | 241 | 283 | |
Movements | |||||
Additions from new leases | 6 | 17 | 23 | 27 | |
Acquired through business combinations | 3 | 1 | 4 | 0 | |
Additions from contract modifications and reassessment of options | 13 | 1 | 14 | 8 | |
Other movements from contract | |||||
modifications and reassessment of options | (15) | (1) | (16) | (4) | |
Net additions | 7 | 18 | 25 | 31 | |
Depreciation | Note 13 | (47) | (13) | (60) | (67) |
Foreign exchange differences | 7 | 1 | 8 | (6) | |
Total movements | (33) | 6 | (27) | (42) | |
Position at December 31 | |||||
Cost value | 556 | 53 | 609 | 623 | |
Accumulated depreciation and impairment | (367) | (28) | (395) | (382) | |
Book value at December 31 | 189 | 25 | 214 | 241 |
Contractual maturities of lease liabilities | |||
2024 | 2023 | ||
Within one year | 65 | 65 | |
Between one and two years | 53 | 55 | |
Between two and three years | 44 | 44 | |
Between three and four years | 34 | 36 | |
Between four and five years | 24 | 30 | |
Between five and ten years | 48 | 72 | |
Ten years and more | – | 1 | |
Effect of discounting | (26) | (31) | |
Total lease liabilities at December 31 | Note 28 | 242 | 272 |
Cash outflow for leases | ||
2024 | 2023 | |
Interest portion of lease payments | 8 | 9 |
Repayment of principal portion of lease liabilities | 62 | 65 |
Total | 70 | 74 |
ownership in % | 2024 | 2023 |
Haoyisheng (Beijing, China) | 22 | 22 |
Movement schedule of equity-accounted associates | ||
2024 | 2023 | |
Position at January 1 | 11 | 11 |
Share of profit of equity-accounted associates, net of tax | 2 | 1 |
Foreign exchange differences | 0 | (1) |
Position at December 31 | 13 | 11 |
Total equity-accounted | ||||
associates | Group’s share | |||
2024 | 2023 | 2024 | 2023 | |
Total assets | 43 | 38 | 9 | 8 |
Total liabilities | 26 | 22 | 5 | 5 |
Total equity | 17 | 16 | 4 | 3 |
Revenues | 26 | 30 | 6 | 6 |
Net profit for the year | 2 | 3 | 2 | 1 |
Note 21 – Financial assets | ||
2024 | 2023 | |
Financial assets at fair value through profit or loss | 0 | 0 |
Finance lease receivables | 1 | 1 |
Other non-current financial assets | 4 | 5 |
Total | 5 | 6 |
Deferred tax assets and liabilities | ||||
temporary differences arising from: | Assets | Liabilities | 2024 | 2023 |
Intangible assets | 6 | (430) | (424) | (392) |
Property, plant, and equipment, right-of-use | ||||
assets, and lease liabilities | 76 | (57) | 19 | 21 |
Employee benefits | 42 | – | 42 | 37 |
Tax value of loss carry-forwards recognized | 17 | – | 17 | 23 |
Other items | 106 | (28) | 78 | 81 |
Total before set-off of tax | 247 | (515) | (268) | (230) |
Set-off of tax | (191) | 191 | 0 | 0 |
Position at December 31 | 56 | (324) | (268) | (230) |
Movements in temporary differences 2024 | ||||||
Recognized | Recognized in | |||||
Balance at | in profit or | equity and OCI | Foreign | Balance at | ||
January 1, | Acquisitions/ | loss | comprehensive | exchange | December | |
2024 | divestments | (Note 15) | income | differences | 31, 2024 | |
Intangible assets | (392) | (44) | 31 | – | (19) | (424) |
PPE, right-of-use | ||||||
assets, and lease | ||||||
liabilities | 21 | – | (2) | – | 0 | 19 |
Employee benefits | 37 | – | 1 | 1 | 3 | 42 |
Tax value of loss carry- forwards recognized | 23 | – | (8) | – | 2 | 17 |
Other items | 81 | (1) | (10) | 4 | 4 | 78 |
Total | (230) | (45) | 12 | 5 | (10) | (268) |
Movements in temporary differences 2023 | ||||||
Recognized | Recognized in | |||||
Balance at | in profit or | equity and OCI | Foreign | Balance at | ||
January 1, | Acquisitions/ | loss | comprehensive | exchange | December | |
2023 | divestments | (Note 15) | income | differences | 31, 2023 | |
Intangible assets | (395) | (7) | 1 | – | 9 | (392) |
PPE, right-of-use | ||||||
assets, and lease | ||||||
liabilities | 17 | – | 4 | – | 0 | 21 |
Employee benefits | 38 | – | 0 | 0 | (1) | 37 |
Tax value of loss | ||||||
carry-forwards | ||||||
recognized | 31 | – | (7) | – | (1) | 23 |
Other items | 72 | (1) | 10 | 0 | 0 | 81 |
Total | (237) | (8) | 8 | 0 | 7 | (230) |
Movements in overall tax position | |||
Position at January 1 | 2024 | 2023 | |
Current income tax assets | 86 | 61 | |
Current income tax liabilities | (128) | (129) | |
Deferred tax assets | 51 | 62 | |
Deferred tax liabilities | (281) | (299) | |
Overall tax position | (272) | (305) | |
Movements | |||
Total income tax expense | Note 15 | (299) | (290) |
Deferred tax from acquisitions and divestments | (45) | (8) | |
Current income tax from acquisitions and divestments | 0 | 0 | |
Deferred tax on items recognized directly in OCI | 5 | 0 | |
Paid income tax | 318 | 325 | |
Foreign exchange differences | (10) | 6 | |
Total movements | (31) | 33 | |
Position at December 31 | |||
Current income tax assets | 82 | 86 | |
Current income tax liabilities | (117) | (128) | |
Deferred tax assets | 56 | 51 | |
Deferred tax liabilities | (324) | (281) | |
Overall tax position | (303) | (272) |
Deferred tax on items recognized immediately in other comprehensive income and equity | ||||||
2024 | 2023 | |||||
Amount | Amount | Amount | Amount | |||
before | net of | before | net of | |||
Exchange differences on translation of foreign operations, recycling of foreign | tax | Tax | tax | tax | Tax | tax |
exchange differences on loss of control, and net investment hedges | 214 | 0 | 214 | (124) | 0 | (124) |
Gains/(losses) on cash flow hedges | (7) | 4 | (3) | (7) | – | (7) |
Remeasurement gains/(losses) on defined | ||||||
benefit plans | (5) | 1 | (4) | (1) | 0 | (1) |
Recognized in other comprehensive income | 202 | 5 | 207 | (132) | 0 | (132) |
Share-based payments | 31 | – | 31 | 31 | – | 31 |
Recognized in equity | 31 | 0 | 31 | 31 | 0 | 31 |
Note 23 – Inventories | ||
2024 | 2023 | |
Work in progress | 18 | 27 |
Finished products and trade goods | 61 | 57 |
Total | 79 | 84 |
2024 | 2023 | |
Trade receivables | 1,129 | 1,087 |
Non-current contract assets | 18 | 18 |
Current contract assets | 148 | 160 |
Non-current deferred income | 110 | 102 |
Current deferred income | 2,054 | 1,899 |
Other current contract liabilities | 76 | 86 |
Loss allowances | |||
2024 | 2023 | ||
Position at January 1 | 85 | 85 | |
Additions to loss allowances | Note 9 | 35 | 34 |
Releases from loss allowances | Note 9 | (17) | (11) |
Usage of loss allowances | (23) | (22) | |
Foreign exchange differences | 9 | (1) | |
Position at December 31 | 89 | 85 |
Contract assets | ||||||
Cost to | Cost to | |||||
Unbilled | obtain a | fulfill a | ||||
current and non-current | revenues | contract | contract | 2024 | 2023 | |
Position at January 1 | 97 | 41 | 40 | 178 | 170 | |
Recognized as revenues in the year | 443 | – | – | 443 | 502 | |
Newly recognized cost to fulfill a contract | – | – | 405 | 405 | 519 | |
Transferred to trade receivables | (462) | – | (404) | (866) | (1,007) | |
Newly recognized cost to obtain a contract | – | 31 | – | 31 | 30 | |
Amortization of capitalized sales | ||||||
commissions | Note 9 | – | (29) | – | (29) | (29) |
Autonomous movements in contract | ||||||
assets | (19) | 2 | 1 | (16) | 15 | |
Acquired through business | ||||||
combinations | – | – | – | 0 | 0 | |
Foreign exchange differences | 2 | 0 | 2 | 4 | (7) | |
Position at December 31 | 80 | 43 | 43 | 166 | 178 |
Deferred income | ||
current and non-current | 2024 | 2023 |
Position at January 1 | 2,001 | 1,970 |
New and existing contracts with customers | 4,668 | 4,300 |
Recognized as revenues from opening balance | (1,899) | (1,858) |
Recognized as revenues in the year on new and existing contracts | (2,650) | (2,309) |
Change in netting against trade receivables | (46) | (53) |
Autonomous movements in deferred income | 73 | 80 |
Acquired through business combinations | 4 | 6 |
Divestment of operations | (6) | – |
Foreign exchange differences | 92 | (55) |
Position at December 31 | 2,164 | 2,001 |
Other contract liabilities | ||
2024 | 2023 | |
Position at January 1 | 86 | 88 |
Additions to provision for returns, refunds, and other | 130 | 121 |
Usage of provision for returns, refunds, and other | (139) | (121) |
Autonomous movements in other contract liabilities | (9) | 0 |
Foreign exchange differences | (1) | (2) |
Position at December 31 | 76 | 86 |
Note 25 – Other receivables | |||
2024 | 2023 | ||
Prepaid royalties | 11 | 14 | |
Non-current other receivables | 11 | 14 | |
Prepaid royalties | 70 | 56 | |
Other prepayments | 154 | 116 | |
VAT, sales tax, and other taxation | 22 | 16 | |
Miscellaneous receivables | 16 | 10 | |
Interest receivable | 1 | 2 | |
Collateral | 2 | – | |
Deferred divestment receivables | 0 | – | |
Derivative financial instruments | Note 29 | – | 2 |
Current other receivables | 265 | 202 |
Note 26 – Cash and cash equivalents | |||
2024 | 2023 | ||
Deposits | 417 | 649 | |
Cash and bank balances | 537 | 486 | |
Total cash and cash equivalents in the consolidated statement | |||
of financial position | 954 | 1,135 | |
Minus: Bank overdrafts used for cash management purposes | Note 28 | (9) | (146) |
Total cash and cash equivalents minus bank overdrafts | 945 | 989 |
Note 27 – Trade and other payables | |||
2024 | 2023 | ||
Trade payables | 159 | 165 | |
Salaries, holiday allowances, and other benefits | 326 | 285 | |
VAT, sales tax, social security premiums, and other taxation | 99 | 91 | |
Pension-related payables | 32 | 28 | |
Royalty payables | 104 | 87 | |
Other accruals and payables | 311 | 295 | |
Interest payable | 51 | 42 | |
Deferred and contingent acquisition payables | Note 29 | 2 | 4 |
Derivative financial instruments | Note 29 | 3 | – |
Total | 1,087 | 997 |
Nominal | |||||||
Effective | interest | Repayment | Repayment | ||||
in millions of euros, unless | Nominal | interest | rate in | commitments | commitments | ||
otherwise stated | value | rate in % | % | 1-5 years | >5 years | 2024 | 2023 |
Bonds 2008-2028 (100.00 * ) | €36 | 6.812 | 6.748 | 36 | – | 36 | 36 |
Bonds 2017-2027 (99.659 * ) | €500 | 1.575 | 1.500 | 499 | – | 499 | 499 |
Bonds 2020-2030 (99.292 * ) | €500 | 0.862 | 0.750 | – | 497 | 497 | 496 |
Bonds 2021-2028 (99.958 * ) | €500 | 0.307 | 0.250 | 499 | – | 499 | 499 |
Bonds 2022-2026 (99.922 * ) | €500 | 3.096 | 3.000 | 499 | – | 499 | 499 |
Bonds 2023-2031 (99.417 * ) | €700 | 3.877 | 3.750 | – | 695 | 695 | 694 |
Bonds 2024-2029 (99.964 * ) | €600 | 3.316 | 3.250 | 599 | – | 599 | – |
Bonds, measured at amortized cost | 2,132 | 1,192 | 3,324 | 2,723 | |||
Private placements | |||||||
2008-2038, measured at amortized cost | – | 122 | 122 | 127 | |||
Deferred and contingent | |||||||
acquisition payables, measured at fair value | 0 | – | 0 | 1 | |||
Other debt, measured at amortized cost | 21 | – | 21 | 21 | |||
Derivative financial | |||||||
instruments, measured | |||||||
at fair value ** | – | 17 | 17 | 5 | |||
Other long-term debt | 21 | 17 | 38 | 27 | |||
Total long-term debt | |||||||
(excluding lease liabilities) | 2,153 | 1,331 | 3,484 | 2,877 | |||
Lease liabilities *** | 179 | 209 | |||||
Total long-term debt | 3,663 | 3,086 |
Reconciliation long-term debt to net debt | |||
2024 | 2023 | ||
Total long-term debt | 3,663 | 3,086 | |
Borrowings and bank overdrafts: | |||
Euro Commercial Paper program | 350 | 50 | |
Bank overdrafts, measured at amortized cost | Note 26 | 9 | 146 |
Total borrowings and bank overdrafts | 359 | 196 | |
Bonds 2014-2024 | – | 400 | |
Short-term lease liabilities | 63 | 63 | |
Deferred and contingent acquisition payables measured | |||
at fair value | Note 29 | 2 | 4 |
Derivative financial instruments | Note 29 | 3 | – |
Total short-term debt | 427 | 663 | |
Gross debt | 4,090 | 3,749 | |
Minus: | |||
Cash and cash equivalents | Note 26 | (954) | (1,135) |
Collateral | (2) | – | |
Deferred divestment consideration receivable | Note 8 | 0 | – |
Derivative financial instruments: | |||
Non-current assets | Note 21 | – | – |
Current assets | Note 25 | – | (2) |
Net debt | 3,134 | 2,612 |
Gross debt, excluding lease liabilities, derivative financial instruments, and bank overdrafts | |||||||
Balance at | Foreign | Other | Balance at | ||||
January 1, | Net cash | Acquisitions/ | Unwinding | exchange | non-cash | December | |
2024 | flows | Divestments | of discount | differences | movements | 31, 2024 | |
Bonds | 3,123 | 200 | – | 3 | – | (2) | 3,324 |
Private | |||||||
placements | 127 | – | – | – | (5) | – | 122 |
Other gross debt | 76 | 299 | (3) | – | 1 | – | 373 |
Total | 3,326 | 499 | (3) | 3 | (4) | (2) | 3,819 |
Balance at | Foreign | Other | Balance at | ||||
January 1, | Net cash | Acquisitions/ | Unwinding | exchange | non-cash | December | |
2023 | flows | Divestments | of discount | differences | movements | 31, 2023 | |
Bonds | 3,126 | (4) | – | 3 | – | (2) | 3,123 |
Private | |||||||
placements | 142 | – | – | 0 | (15) | – | 127 |
Other gross debt | 20 | 55 | 1 | – | 0 | – | 76 |
Total | 3,288 | 51 | 1 | 3 | (15) | (2) | 3,326 |
Lease liabilities | |||
current and non current | 2024 | 2023 | |
Position at January 1 | 272 | 313 | |
Additions from new leases | 23 | 27 | |
Acquired through business combinations | 4 | 0 | |
Contract modifications and reassessments of options | (4) | 4 | |
Repayment of lease liabilities (interest and principal portion) | (70) | (74) | |
Unwinding of discount of lease liabilities | Note 14 | 8 | 9 |
Foreign exchange differences | 9 | (7) | |
Position at December 31 | Note 19 | 242 | 272 |
2024 | |
2026 | 510 |
2027 | 509 |
2028 | 535 |
2029 | 599 |
Due after 2029 | 1,331 |
Long-term debt | 3,484 |
Short-term debt (2025) | 364 |
Total (excluding lease liabilities) | 3,848 |
2024 | 2023 | |
Revenues | (40) | (38) |
Adjusted operating profit | (14) | (13) |
Operating profit | (13) | (12) |
Adjusted net profit | (12) | (8) |
Profit for the year | (11) | (8) |
Shareholders’ equity at December 31 | (29) | (36) |
Adjusted free cash flow | (12) | (11) |
Exchange | Interest | ||||
in millions, unless | Type of | rate movement | rate movement | ||
otherwise stated | Hedged risk | Amount | instrument | € | € |
Changes in ¥ floating | Cross-currency | ||||
interest payments and | interest | ||||
Cash flow hedge | ¥ exchange rates | ¥20,000 | rate swaps | (1) | 0 |
Changes of the U.S. dollar | |||||
net investments due to | |||||
Net investment | fluctuations of U.S. dollar | Forward | |||
hedge | exchange rates | $300 | contracts 3 0 |
Contractual cash flows 2024 | Contractual cash flows 2023 | ||||||||||||
Contractual | Less | More | Contractual | Less | More | ||||||||
Carrying | undiscounted | than | 1-2 | 2-5 | than | Carrying | undiscounted | than | 1-2 | 2-5 | than | ||
Non-derivative financial liabilities | amount | cash flows | 1 year | years | years | 5 years | Non-derivative financial liabilities | amount | cash flows | 1 year | years | years | 5 years |
(excl. lease liabilities) | (excl. lease liabilities) | ||||||||||||
Bonds: | Bonds: | ||||||||||||
Bonds 2008-2028 | 36 | 45 | 2 | 2 | 41 | – | Bonds 2008-2028 | 36 | 47 | 2 | 2 | 43 | – |
Bonds 2017-2027 | 499 | 524 | 8 | 8 | 508 | – | Bonds 2014-2024 | 400 | 410 | 410 | – | – | – |
Bonds 2020-2030 | 497 | 523 | 4 | 4 | 11 | 504 | Bonds 2017-2027 | 499 | 531 | 8 | 8 | 515 | – |
Bonds 2021-2028 | 499 | 505 | 1 | 1 | 503 | – | Bonds 2020-2030 | 496 | 527 | 4 | 4 | 11 | 508 |
Bonds 2022-2026 | 499 | 530 | 15 | 515 | – | – | Bonds 2021-2028 | 499 | 506 | 1 | 1 | 504 | – |
Bonds 2023-2031 | 695 | 884 | 26 | 26 | 79 | 753 | Bonds 2022-2026 | 499 | 545 | 15 | 15 | 515 | – |
Bonds 2024-2029 | 599 | 699 | 20 | 20 | 659 | – | Bonds 2023-2031 | 694 | 910 | 26 | 26 | 79 | 779 |
Private placements: | Private placements: | ||||||||||||
Private placements 2008-2038 | 122 | 177 | 4 | 4 | 12 | 157 | Private placements 2008-2038 | 127 | 189 | 4 | 4 | 13 | 168 |
Long- and short-term deferred and | Long- and short-term deferred and | ||||||||||||
contingent acquisition payables | 2 | 2 | 2 | 0 | – | – | contingent acquisition payables | 5 | 5 | 4 | 1 | – | – |
Other debt | 21 | 21 | – | 11 | 10 | – | Other debt | 21 | 21 | – | 11 | 10 | – |
Borrowings and bank overdrafts | 359 | 359 | 359 | – | – | – | Borrowings and bank overdrafts | 196 | 196 | 196 | – | – | – |
Trade payables | 159 | 159 | 159 | – | – | – | Trade payables | 183 | 183 | 183 | – | – | – |
Total | 3,987 | 4,428 | 600 | 591 | 1,823 | 1,414 | Total | 3,655 | 4,070 | 853 | 72 | 1,690 | 1,455 |
Derivative financial instruments | Derivative financial instruments | ||||||||||||
(Receipts) (286) | (286) | (Receipts) | (252) | (252) | |||||||||
Payments | 281 | 281 | Payments | 249 | 249 | ||||||||
Foreign exchange derivatives | 3 | (5) | (5) | 0 | 0 | 0 | Foreign exchange derivatives | (2) | (3) | (3) | 0 | 0 | 0 |
(Receipts) | (177) | (4) | (4) | (12) | (157) | (Receipts) | (189) | (4) | (4) | (13) | (168) | ||
Payments | 230 | 8 | 8 | 23 | 191 | Payments | 238 | 8 | 8 | 23 | 199 | ||
Cross-currency interest rate swaps | 17 | 53 | 4 | 4 | 11 | 34 | Cross-currency interest rate swaps | 5 | 49 | 4 | 4 | 10 | 31 |
Total derivative financial liabilities/(assets) | 20 | 48 | (1) | 4 | 11 | 34 | Total derivative financial liabilities/(assets) | 3 | 46 | 1 | 4 | 10 | 31 |
2024 | 2023 | ||||||
Non-derivative financial instruments: | Carrying value | Fair value | Level 1 | Level 2 | Level 3 | Carrying value | Fair value |
Financial assets at fair value through profit or loss | 0 | 0 | 0 | 0 | 0 | ||
Unbilled revenues * | 80 | 80 | 97 | 97 | |||
Trade receivables * | 1,129 | 1,129 | 1,087 | 1,087 | |||
VAT, sales tax, and other taxation * | 22 | 22 | 16 | 16 | |||
Miscellaneous receivables * | 16 | 16 | 10 | 10 | |||
Interest receivable * | 1 | 1 | 2 | 2 | |||
Deferred divestment consideration receivable * | 0 | 0 | – | – | |||
Cash and cash equivalents * | 954 | 954 | 1,135 | 1,135 | |||
Total non-derivative financial assets | 2,202 | 2,202 | 0 | 2,347 | 2,347 | ||
Bonds 2008-2028 | 36 | 40 | 40 | 36 | 41 | ||
Bonds 2014-2024 | – | – | 400 | 398 | |||
Bonds 2017-2027 | 499 | 487 | 487 | 499 | 479 | ||
Bonds 2020-2030 | 497 | 444 | 444 | 496 | 435 | ||
Bonds 2021-2028 | 499 | 462 | 462 | 499 | 449 | ||
Bonds 2022-2026 | 499 | 501 | 501 | 499 | 501 | ||
Bonds 2023-2031 | 695 | 723 | 723 | 694 | 727 | ||
Bonds 2024-2029 | 599 | 609 | 609 | ||||
Private placements 2008-2038 | 122 | 140 | 140 | 127 | 149 | ||
Long- and short-term deferred and contingent acquisition payables | 2 | 2 | 2 | 5 | 5 | ||
Other debt * | 21 | 21 | 21 | 21 | |||
Borrowings and bank overdrafts * | 359 | 359 | 196 | 196 | |||
Trade payables * | 159 | 159 | 183 | 183 | |||
Interest payable * | 51 | 51 | 42 | 42 | |||
Total non-derivative financial liabilities | 4,038 | 3,998 | 3,266 | 140 | 2 | 3,697 | 3,626 |
Derivative financial instruments: | |||||||
Non-current assets | – | – | – | – | |||
Current assets | – | – | 2 | 2 | |||
Total derivative financial assets | 0 | 0 | 2 | 2 | |||
Non-current liabilities | 17 | 17 | 17 | 5 | 5 | ||
Current liabilities | 3 | 3 | 3 | – | – | ||
Total derivative financial liabilities | 20 | 20 | 20 | 5 | 5 |
2024 | 2023 | ||
Balance at January 1 | 5 | 4 | |
Acquired through business combinations | Note 8 | 0 | 4 |
Settlements | Note 8 | (3) | (3) |
Fair value changes of contingent considerations | Note 11 | 0 | 0 |
Foreign exchange differences | 0 | 0 | |
Balance at December 31 | 2 | 5 |
Fair value | Maximum | Fair value | |||
December 31, | Of which: | Of which: | exposure | December 31, | |
2024 | short term | long term | (undiscounted) | 2023 | |
Total | 2 | 2 | 0 | 2 | 5 |
Note 30 – Employee benefits | ||
2024 | 2023 | |
Retirement plans | 11 | 29 |
Other post-employment benefit plans | 47 | 45 |
Other long-term employment benefits | 9 | 7 |
Total | 67 | 81 |
Characteristics of material plans | |||
Retirement plans | The Netherlands | United States | United Kingdom |
Type of benefits | Pensions | Pensions | Pensions |
Type of plan | Career average | Final salary | Final salary |
Status of plan | Open | Frozen | Frozen |
Service costs | Yes | No | No |
Status of plan funding | Funded | Funded | Funded |
Other post-employment plans | Post-retirement | ||
Type of benefits | medical plan | ||
Annual insurance | |||
Type of plan | premium coverage | ||
Status of plan | Closed | ||
Service costs | Yes | ||
Status of plan funding | Unfunded |
in % | 2024 | 2023 |
Retirement plans | ||
Discount rate to discount the obligations at year end | 3.6 | 3.3 |
Discount rate for pension expense | 3.3 | 3.9 |
Expected rate of pension increases (in payment) at year end | 3.1 | 2.6 |
Expected rate of pension increases (in deferral) at year end | 3.1 | 2.5 |
Expected rate of inflation increase for pension expense | 2.2 | 2.1 |
Other post-employment benefit plans | ||
Discount rate to discount the obligations at year end | 4.8 | 4.3 |
Discount rate for pension expense | 4.3 | 4.6 |
Medical cost trend rate | 3.0 | 3.0 |
in years | The Netherlands | United States | United Kingdom |
Life expectancy at age of 65 now – Male | 21.9 | 20.7 | 21.5 |
Life expectancy at age of 65 now – Female | 24.3 | 22.6 | 23.6 |
Life expectancy aged 65 in 20 years – Male | 23.9 | 22.8 | 22.5 |
Life expectancy aged 65 in 20 years – Female | 26.3 | 25.1 | 25.0 |
Sensitivity retirement plans | ||||
Gross service cost | ||||
(excluding interest) | Defined benefit obligations | |||
2024 | Baseline | 17 | 1,369 | |
Decrease of | Increase of | Decrease of | Increase of | |
Change compared to baseline | assumption | assumption | assumption | assumption |
Discount rate (change by 1%) | 6 | (4) | 240 | (189) |
Pension increase rate (change by 0.5%) | (2) | 2 | (93) | 104 |
Inflation increase rate (change by 0.5%) | (2) | 3 | (129) | 151 |
Mortality table (change by one year) | – | 0 | (66) | 57 |
Sensitivity of the defined benefit obligations (DBO) of retirement plans in the consolidated | |||||
statement of financial position and the defined benefit expense of the retirement plans | |||||
in the consolidated statement of profit or loss (P&L) | The Netherlands | United States | United Kingdom | ||
DBO | P&L | DBO | P&L | DBO | P&L |
Discount rate sensitivity | – | – | |||
Pension increase sensitivity | – | – | – | ||
Inflation rate sensitivity | – | – | – | ||
Mortality sensitivity | – | – |
Sensitivity of other post-employment plans | |||
Gross service costs | |||
in millions of euro | (excluding interest) | Defined benefit obligations | |
2024 | Baseline | 1 | 47 |
Change compared to baseline | |||
Discount rate (by -1%) | 0 | 4 | |
Discount rate (by +1%) | 0 | (3) |
Defined benefit | Other post- | |||||||||
Plan liabilities and plan assets | retirement plans | employment plans | ||||||||
Defined benefit | Other post- | 2024 | 2023 | 2024 | 2023 | |||||
retirement plans | employment plans | Pension expenses | ||||||||
2024 | 2023 | 2024 | 2023 | Employer service cost | 15 | 13 | 1 | 1 | ||
Plan liabilities | Past service costs – plan amendment | (27) | – | – | – | |||||
Fair value at January 1 | 1,352 | 1,263 | 45 | 44 | Interest expense on irrecoverable surplus | 0 | 0 | – | – | |
Employer service cost | 15 | 13 | 1 | 1 | Interest expense on defined benefit obligations | 44 | 48 | 2 | 2 | |
Interest expense on defined benefit obligations | 44 | 48 | 2 | 2 | Interest income on plan assets | (44) | (47) | – | – | |
Administration costs and taxes | 2 | 2 | – | – | Administration costs and taxes | 2 | 2 | – | 0 | |
Benefits paid by fund | (55) | (54) | – | – | Total pension expense | (10) | 16 | 3 | 3 | |
Benefits paid by employer | – | – | (3) | (3) | Of which is included in: | |||||
Remeasurement (gains)/losses | 25 | 78 | 0 | 2 | Employee benefit expenses | Note 12 | (11) | 15 | 1 | 1 |
Acquired through business combinations | 1 | – | 0 | 0 | Other finance (income)/costs | Note 14 | 1 | 1 | 2 | 2 |
Contributions by plan participants | 4 | 4 | – | – | ||||||
Plan amendments and curtailments | (27) | – | – | – | ||||||
Foreign exchange differences | 8 | (2) | 2 | (1) | ||||||
Fair value at December 31 | 1,369 | 1,352 | 47 | 45 | ||||||
Plan assets | ||||||||||
Fair value at January 1 | 1,337 | 1,240 | 0 | 0 | ||||||
Interest income on plan assets | 44 | 47 | – | – | ||||||
Return on plan assets greater than discount rate | 6 | 82 | – | – | ||||||
Benefits paid by fund | (55) | (54) | (3) | (3) | ||||||
Acquired through business combinations | 1 | – | – | – | ||||||
Contributions by employer | 13 | 19 | 3 | 3 | ||||||
Contributions by plan participants | 4 | 4 | – | – | ||||||
Foreign exchange differences | 8 | (1) | – | – | ||||||
Fair value at December 31 | 1,358 | 1,337 | 0 | 0 | ||||||
Funded status | ||||||||||
Deficit/(surplus) at December 31 | 11 | 15 | 47 | 45 | ||||||
Irrecoverable surplus | 0 | 14 | – | – | ||||||
Net liability at December 31 | 11 | 29 | 47 | 45 |
2024 | 2023 | |
Position at January 1 | (121) | (120) |
Recognized in other comprehensive income | (5) | (1) |
Cumulative amount at December 31 | (126) | (121) |
Remeasurement gains/(losses) for the year | ||
2024 | 2023 | |
Remeasurement gains/(losses) due to experience adjustments | 16 | (62) |
Remeasurement gains/(losses) due to changes in demographic assumptions | 3 | 3 |
Remeasurement gains/(losses) due to changes in financial assumptions | (44) | (21) |
Remeasurement gains/(losses) on defined benefit obligations | (25) | (80) |
Return on plan assets greater/(lower) than discount rate | 6 | 82 |
Change in irrecoverable surplus, other than interest and foreign | ||
exchange differences | 14 | (3) |
Recognized remeasurement gains/(losses) on defined benefit plans in other comprehensive income | (5) | (1) |
number of years | 2024 | 2023 |
Retirement plans | ||
The Netherlands | 16.5 | 16.7 |
United Kingdom | 10.7 | 11.5 |
United States | 8.7 | 9.3 |
Other post-employment plans | ||
United States | 6.3 | 6.7 |
Equity | 2024 | Quoted | Unquoted | 2023 | Quoted | Unquoted |
Equity | 392 | 392 | – | 355 | 355 | – |
Private equity | 1 | – | 1 | 1 | – | 1 |
Bonds | ||||||
Government bonds | 396 | 396 | – | 476 | 476 | – |
Corporate bonds | 177 | 177 | – | 183 | 183 | – |
Other bonds | – | – | – | 11 | 11 | – |
Asset-backed securities | 111 | 111 | – | 87 | 87 | – |
Other Insurance contracts | 205 | 77 | 128 | 130 | – | 130 |
Real estate | 97 | 45 | 52 | 93 | 42 | 51 |
Derivatives and other securities | (27) | (27) | – | (20) | (20) | – |
Cash | 6 | 6 | – | 21 | 21 | – |
Total | 1,358 | 1,177 | 181 | 1,337 | 1,155 | 182 |
Proportion of plan assets | ||
in % | 2024 | 2023 |
Equity | 29 | 27 |
Bonds | 50 | 57 |
Other | 21 | 16 |
Total | 100 | 100 |
Note 31 – Provisions | ||
2024 | 2023 | |
Provision for restructuring commitments | 15 | 7 |
Provision for acquisition integration | 1 | 1 |
Restructuring provisions | 16 | 8 |
Legal provisions | 11 | 12 |
Other provisions | 6 | 6 |
Total | 33 | 26 |
Of which short term | 28 | 21 |
Movements in provisions | ||||||
Restructuring | Legal | Other | ||||
Long-term provisions at | provisions | provisions | provisions | 2024 | 2023 | |
January 1 | 0 | 1 | 4 | 5 | 5 | |
Add: short-term provisions | 8 | 11 | 2 | 21 | 19 | |
Total provisions at January 1 | 8 | 12 | 6 | 26 | 24 | |
Movements | ||||||
Additions for restructuring | ||||||
of stranded costs | Note 8 | 1 | – | – | 1 | 0 |
Additions for acquisition | ||||||
integration | Note 11 | 0 | – | – | 0 | 4 |
Other additions | 16 | 1 | 1 | 18 | 10 | |
Total additions | 17 | 1 | 1 | 19 | 14 | |
Appropriation of provisions | (7) | (2) | 0 | (9) | (10) | |
Release of provisions | (2) | (1) | (2) | (5) | (2) | |
Exchange differences | 1 | 1 | 0 | 2 | 0 | |
Total movements | 9 | (1) | (1) | 7 | 2 | |
Total provisions at December 31 | 17 | 11 | 5 | 33 | 26 | |
Less: short-term provisions | (16) | (9) | (3) | (28) | (21) | |
Long-term provisions at December 31 | 1 | 2 | 2 | 5 | 5 |
Number of shares | ||||||
Number of | Minus: number of | Total number of ordinary | ||||
ordinary shares | treasury shares | shares outstanding | ||||
in thousands of shares, unless | ||||||
otherwise stated | 2023 | 2024 | 2024 | 2023 | 2024 | 2023 |
At January 1 | 257,516 | 248,516 | (8,005) | (8,802) | 240,511 | 248,714 |
Cancelation of shares | (9,000) | (10,000) | 10,000 | 9,000 | 0 | 0 |
Repurchased shares | – | – | (6,701) | (8,738) | (6,701) | (8,738) |
Long-term incentive plan | – | – | 556 | 535 | 556 | 535 |
At December 31 | 248,516 | 238,516 | (4,150) | (8,005) | 234,366 | 240,511 |
Issued share capital at €0.12 (€’000) | 29,822 | 28,622 | ||||
Proposed dividend per share (€) | 2.33 | 2.08 | ||||
Proposed dividend distribution | ||||||
(€’000) | 547,818 | 502,722 |
Dividend distributions over financial year | |||
2024 | 2023 | 2022 | |
Originally proposed dividend over financial year | 548 | 503 | 453 |
Actual payments: | |||
Interim dividend (paid in the financial year) | 196 | 176 | 160 |
Final dividend (paid in the subsequent financial year) | 324 | 291 | |
Total dividend distribution | 500 | 451 |
Note 33 – Share-based payments | ||
2024 | 2023 | |
Long-term incentive plan | 27 | 29 |
Restricted Stock Units | 4 | 2 |
Total equity-settled share-based payments | 31 | 31 |
Fair value of Adjusted EPS and | Fair value TSR shares | |
in euros | ROIC shares at grant date | at grant date |
LTIP 2024-26 | 121.35 | 86.87 |
LTIP 2023-25 | 91.37 | 68.72 |
LTIP 2022-24 | 97.82 | 71.71 |
LTIP 2021-23 | 64.06 | 47.03 |
LTIP 2021-23: number of shares vested and the cash equivalent thereof | ||||||
Increase in | Increase in | Increase in | Payout/ | |||
conditional | conditional | conditional | vested | |||
number of shares, | Outstanding | number of | number of | number of | shares | Cash value |
unless otherwise | at December | EPS shares | ROIC shares | TSR shares | February 22, | vested |
stated | 31, 2023 | (50%) | (50%) | (25%) | 2024 | shares * |
Executive Board | 93,503 | 11,876 | 7,918 | 13,480 | 126,777 | 18,656 |
Senior management | 303,256 | 45,564 | 30,408 | 37,944 | 417,172 | 61,388 |
Total | 396,759 | 57,440 | 38,326 | 51,424 | 543,949 | 80,044 |
LTIP 2022-24 | ||||
Adjusted EPS- | ROIC- | TSR- | ||
number of shares | Total | condition | condition | condition |
Conditionally awarded grant 2022 | 303,253 | 88,324 | 58,886 | 156,043 |
Forfeited in previous years | (19,773) | (5,930) | (3,953) | (9,890) |
Shares outstanding at January 1, 2024 | 283,480 | 82,394 | 54,933 | 146,153 |
Forfeited during the year | (26,736) | (8,021) | (5,349) | (13,366) |
Effect of 145% vesting – EPS-performance | 33,469 | 33,469 | – | – |
Effect of 150% vesting – ROIC-performance | 24,864 | – | 24,864 | – |
Effect of 125% vesting – TSR-ranking | 33,222 | – | – | 33,222 |
Vested at December 31, 2024 | 348,299 | 107,842 | 74,448 | 166,009 |
LTIP 2023-25 | ||||
Adjusted EPS- | ROIC- | TSR- | ||
base number of shares at 100% payout | Total | condition | condition | condition |
Conditionally awarded grant 2023 | 338,699 | 98,605 | 65,708 | 174,386 |
Forfeited in previous years | (989) | (297) | (198) | (494) |
Shares outstanding at January 1, 2024 | 337,710 | 98,308 | 65,510 | 173,892 |
Forfeited during the year | (33,494) | (10,034) | (6,687) | (16,773) |
Shares outstanding at December 31, 2024 | 304,216 | 88,274 | 58,823 | 157,119 |
LTIP 2024-26 | ||||
Adjusted EPS- | ROIC- | TSR- | ||
base number of shares at 100% payout | Total | condition | condition | condition |
Conditionally awarded grant 2024 | 263,249 | 76,193 | 50,764 | 136,292 |
Forfeited during the year | (7,362) | (2,209) | (1,472) | (3,681) |
Shares outstanding at December 31, 2024 | 255,887 | 73,984 | 49,292 | 132,611 |
Overview of outstanding performance shares: LTIP 2023-25 and LTIP 2024-26 | |||
base numbers of shares at 100% payout | LTIP 2023-25 | LTIP 2024-26 | Total |
Conditionally awarded grant 2023 | 338,699 | – | 338,699 |
Forfeited in previous years | (989) | – | (989) |
Shares outstanding at January 1, 2024 | 337,710 | 0 | 337,710 |
Conditionally awarded grant 2024 | – | 263,249 | 263,249 |
Forfeited during the year | (33,494) | (7,362) | (40,856) |
Shares outstanding at December 31, 2024 | 304,216 | 255,887 | 560,103 |
Fair value | Fair value | Fair value | |
RSU shares | RSU shares | RSU shares | |
at grant date | at grant date | at grant date | |
in euros | March 1 | July 1 | November 1 |
RSU shares 2023 – one-year vesting period | 107.56 | 114.26 | 118.96 |
RSU shares 2023 – two-years vesting period | 105.46 | 111.98 | 116.55 |
RSU shares 2023 – three-years vesting period | 103.11 | 109.43 | 113.86 |
RSU shares 2024 – one-year vesting period | 143.68 | 152.45 | 152.22 |
RSU shares 2024 – two-years vesting period | 141.25 | 149.83 | 149.43 |
RSU shares 2024 – three-years vesting period | 138.72 | 146.88 | 146.30 |
Overview of outstanding performance shares | ||||
Grant date | Grant date | Grant date | ||
Conditionally awarded number of RSU shares, | Total number | March 1, | July 1, | November 1, |
grant 2023 | of RSU shares | 2023 | 2023 | 2023 |
One-year vesting period | 12,873 | 11,951 | 333 | 589 |
Two-years vesting period | 12,845 | 11,924 | 332 | 589 |
Three-years vesting period | 12,752 | 11,832 | 332 | 588 |
Total shares conditionally awarded | 38,470 | 35,707 | 997 | 1,766 |
Forfeitures during the year 2023 | (928) | (928) | – | – |
Shares outstanding at December 31, 2023 | 37,542 | 34,779 | 997 | 1,766 |
Forfeitures during the year 2024 | (1,043) | (1,043) | – | – |
Vesting in 2024 | (12,516) | (11,594) | (333) | (589) |
Shares outstanding at December 31, 2024 | 23,983 | 22,142 | 664 | 1,177 |
Grant date | Grant date | Grant date | ||
Conditionally awarded number of RSU shares, | Total number | March 1, | July 1, | November 1, |
grant 2024 | of RSU shares | 2024 | 2024 | 2024 |
One-year vesting period | 11,678 | 10,701 | 323 | 654 |
Two-years vesting period | 11,549 | 10,575 | 323 | 651 |
Three-years vesting period | 11,451 | 10,477 | 323 | 651 |
Total shares conditionally awarded | 34,678 | 31,753 | 969 | 1,956 |
Forfeitures during the year | (1,137) | (1,137) | – | – |
Shares outstanding at December 31, 2024 | 33,541 | 30,616 | 969 | 1,956 |
Total number | RSU grant in | RSU grant in | |
Total conditionally awarded number of RSU shares | of RSU shares | 2023 | 2024 |
RSU shares outstanding at January 1, 2023 | – | – | – |
Conditionally awarded in 2023 | 38,470 | 38,470 | – |
Forfeitures during the year 2023 | (928) | (928) | – |
RSU shares outstanding at January 1, 2024 | 37,542 | 37,542 | – |
Condionally awarded in 2024 | 34,678 | 34,678 | |
Forfeitures during the year 2024 | (2,180) | (1,043) | (1,137) |
Vesting in 2024 | (12,516) | (12,516) | – |
Shares outstanding at December 31, 2024 | 57,524 | 23,983 | 33,541 |
Audit fees 2024 | |||
Other Deloitte | |||
Deloitte | member firms and | ||
Accountants B.V. | affiliates | Total Deloitte | |
Statutory audit of annual accounts | 1.2 | 2.2 | 3.4 |
CSRD limited assurance | 0.3 | – | 0.3 |
Other assurance services | 0.1 | 0.3 | 0.4 |
Tax advisory services | – | 0.0 | 0.0 |
Other non-audit services | 0.0 | 0.1 | 0.1 |
Total | 1.6 | 2.6 | 4.2 |
Audit fees 2023 | |||
Other Deloitte | |||
Deloitte | member firms and | ||
Accountants B.V. | affiliates | Total Deloitte | |
Statutory audit of annual accounts | 1.0 | 2.3 | 3.3 |
CSRD limited assurance | – | – | 0.0 |
Other assurance services | 0.1 | 0.3 | 0.4 |
Tax advisory services | – | 0.0 | 0.0 |
Other non-audit services | – | 0.0 | 0.0 |
Total | 1.1 | 2.6 | 3.7 |
2024 | 2023 | ||
Parental performance guarantees to third parties | 5 | 5 | |
Guarantee to the trustees of the U.K. retirement plan | Note 30 | 22 | 21 |
Real estate and other guarantees | 10 | 11 | |
Drawn bank credit facilities | 1 | 1 | |
Total | 38 | 38 |
Remuneration Executive Board | ||||
The table below provides the total compensation of the Executive Board recognized in the | ||||
consolidated statement of profit or loss: | ||||
in thousands of euros | 2024 | 2023 | ||
Fixed compensation: | ||||
Salary | 2,387 | 2,308 | ||
Social security | 234 | 247 | ||
Defined contribution plan | 185 | 180 | ||
Other benefits * | 458 | 400 | ||
Total fixed compensation | 3,264 | 3,135 | ||
Variable compensation: | ||||
STIP | 2,998 | 2,736 | ||
LTIP ** | 6,260 | 6,307 | ||
Total variable compensation | 9,258 | 9,043 | ||
Sub-total fixed and variable compensation | 12,522 | 12,178 | ||
Tax-related costs *** | 199 | (459) | ||
Total remuneration Executive Board | 12,721 | 11,719 |